Read More

Harmony Biosciences Announces Exclusive Agreement To Develop And Commercialize TPM-1116, A Highly Potent And Selective Oral Orexin-2 Receptor Agonist; Harmony Will Pay Bioprojet An Upfront License Fee Of $25.5M For The Exclusive Right

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced an exclusive licensing agreement with Bioprojet to develop, manufacture and commercialize TPM-1116, a highly potent and selective oral orexin-2 receptor

HRMY

Read More

Game-Changing Deal: eBay, Collectors Ink Agreement To Boost Trading Card Hobby

eBay solidifies its position in the collectibles market with a definitive agreement with Collectors, parent company of PSA. The agreement entails commercial deals and asset exchanges, promising streamlined experiences for trading card enthusiasts in the U.S. eBay and PSA are set to unveil a customer-centric product experience, including a new service for listing graded trading cards on eBay, enhancing inventory diversity.

EBAY